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Abstract We found that hydrogen peroxide (H202) enhances 
EGF receptor tyrosine phosphorylation in intact cells as well as 
solubilized membrane of an EGF receptor hyperproducing cell 
line NA. An antioxidant MnCI 2 effectively inhibited this enhance- 
ment. Interestingly, overall phosphorylation of the EGF receptor 
enhanced by H202 was half that of the EGF-enhanced phospho- 
rylation when the receptor immunoprecipitated from [32p]ortho- 
phosphate-labeled cells was examined. Tryptic phospho-peptide 
mapping of these receptors revealed that EGF enhanced the phos- 
phorylation on five specific residues including serine 671, 1,046 
and 1,047, threonine 669 and tyrosine 1,173, whereas H202 en- 
hanced the phosphorylation remarkably on tyrosine 1,173 and 
three other residues and only moderately on serine 1,046 and 
1,047 and threonine 669. Thus, H20 2 preferentially enhances the 
tyrosine phosphorylation of EGF receptor through oxidant stress. 
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1. Introduction 
The EGF receptor is a transmembrane glycoprotein of Mr 
170,000 [1 3]. The binding of EGF  to the receptor esults in an 
increase in the tyrosine kinase activity of the receptor cytoplas- 
mic domain [4] and autophosphorylation f the carboxyl-termi- 
nal tyrosine at residues 992, 1,068, 1,086, 1,148 and 1,173 [5 7]. 
Once activated, the receptor initiates a series of signal transduc- 
tion events through tyrosine phosphorylation of interacting 
proteins of SH2 family [1]. Beside tyrosine phosphorylation, the 
in vivo EGF-activated receptors are abundant for the serine/ 
threonine phosphorylation, by which physiological functions 
are attenuated. Various cellular protein kinases such as mito- 
gen-activated protein kinase, casein kinase II, p34 cdc2 kinase 
and Ca2+/calmodulin-dependent kinase II are considered to be 
involved in such phosphorylation and attenuation [8-11]. 
We previously showed that a perylenequinone compound 
calphostin-C enhances EGF  receptor phosphorylation and 
'early response gene' expression in a light-dependent manner 
[12,13]. Since calphostin-C easily accumulates in the membrane 
and induces oxidative modification of protein kinase C in the 
membrane [14], we hypothesized oxidant stress triggers the 
phosphorylation of EGF receptor. Thus, we examined the ef- 
fect of hydrogen peroxide (H202) on cellular phosphorylation 
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Abbreviations: EGF, epidermal growth factor; DMEM, Dulbecco's 
modified Eagle medium; FBS, fetal bovine serum. 
and found that H202 enhances the unique tyrosine phosphoryl- 
ation on EGF  receptor. 
2. Materials and methods 
2.1. EGF receptor phosphorylation 
Human squamous carcinoma cell line NA [15] was grown in 
DMEM supplemented with 10% FBS (DMEM/FBS 10) and kanamycin 
(100 ~tg/ml) in the presence or absence of [32p]orthophosphate (3.7 
MBq/ml, carrier-free, ICN Biomedicals, Irvine, CA, USA) as a tracer 
for 16 h at 5% CO2 and 100% humidity. Then, the cells were treated 
with freshly prepared MnC12 (1 mM), H20~ (1 mM) or EGF (50 ng/ml, 
ultra pure grade, Toyobo Co., Osaka, Japan). The cells were lysed with 
Tris-buffered saline containing 1% Triton X-100 and the EGF receptor 
was immunoprecipitated with monoclonal anti-human EGF receptor 
antibody B4G7 [12,16], electrophoresed on a SDS-polyacrylamide g l
(7%) and transferred to a PVDF membrane (Immobilon-P, Millipore 
Co., Bedford, MA, USA). After incubation in non-fat skim milk (1%) 
for 30 rain, various measurements including autoradiography, quanti- 
tative analysis of radioactivity by a BAS2000 Bio-imaging analyzer 
(Fuji Photo Film Co., Tokyo, Japan), immunostaining analysis and 
tryptic phospho-peptide mapping were carried out. 
The membrane fraction was prepared and in vitro phosphorylation 
assay was carried out as previously described [17,18]. The cells were 
collected in the SAT buffer (0.25 M sucrose, 10 mM acetic acid, 10 mM 
triethanolamine, pH 7.4), and lysed in SEAT buffer (1 mM EDTA in 
SAT buffer) by pipetting with Gilson pipetman, followed by the centrif- 
ugation at 800 rpm for 5 rain to pellet nuclei. The supernatant was 
centrifuged to pellet the membrane at 100,000 rpm for 5 min in a 
Beckman TLAI00.2 rotor. The resulting pellet was resuspended in
HEPES-Triton buffer (20 mM HEPES, 1% Triton X-100, 0.2 mM 
EDTA, 10% glycerol, pH 7.4) and centrifuged at100,000 rpm for 5 min. 
The supernatant was used as the solubilized membrane fraction. The 
reaction mixture for in vitro phosphorylation assay (final volume: 
30/zl) contained 20 mM HEPES (pH 7.4), 1 mM MnC12, 5 ,ug bovine 
serum albumin, 5 ~uM ATE 10~ug membrane protein and 100 ng EGF 
or various concentration of H202. The reaction was initiated by the 
addition of ATE incubated for 10 min on ice, and terminated by the 
addition of Laemmli's ample buffer. 
2.2. lmmunostaining analysis 
The immunoprecipitated EGF receptor was transferred onto the 
membrane, and incubated with anti-phosphotyrosine a tibody (mouse, 
4G10, Upstate Biotechnology Inc., Lake Placid, NY, USA) or anti- 
human EGF receptor antibody (sheep, Upstate Biotechnology Inc.) for 
2 h, with biotinylated second antibody (Zymed Lab., San Francisco, 
CA, USA) for 1 h, and then with avidin-biotin-horseradish peroxidase 
complex (Vector Lab., Burlingame, CA, USA) for 1 h, followed by 
staining. 
2.3. Tryptic pho6pho-peptide mapping 
The EGF receptor which was immunoprecipitated from [32p]ortho- 
phosphate-labeled c lls was transferred to the membrane. After autora- 
diography, the membrane r gion containing the EGF receptor was cut 
out and treated with 2/tg TPCK-trypsin in the presence of 40/lg bovine 
serum albumin at 37°C for 6 h and then treated with an additional 2/lg 
of TPCK-trypsin at 37°C overnight. The resulting peptides were frac- 
tionated by a linear acetonitrile gradient hat ranged from 0% to 50% 
in the presence of trifluoroacetic acid on a Finepak SIL C18 column 
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(Japan Spectroscopic Co., Tokyo, Japan). Phospho-amino acid analy- 
sis was carried out as previously described [12]. 
3. Results 
3. I. H202-enhancement of EGF receptor phosphorylation 
We first examined tyrosine phosphorylation i  an EGF re- 
ceptor-hyperproducing cell line NA after treated with H202 
(1 mM) or EGF by the immunostaining with anti-phosphoty- 
rosine antibody. The protein of approximate M, 170 K was 
detected in crude extracts and those immunoprecipitated by 
both anti-human EGF receptor antibody B4G7 and anti- 
phosphotyrosine antibody (Fig. 1A). Essentially the same 
amounts of EGF receptor protein were detected by the im- 
munostaining with anti-EGF receptor antibody in crude ex- 
tracts and B4G7-immunoprecipitates (Fig. 1B). Thus, it was 
suggested that H202 enhances tyrosine phosphorylation f the 
EGF receptor. The H202-enhanced tyrosine phosphorylation 
of EGF receptor was dose-dependent (maximal at 1 mM) and 
took place within 2.5 min (data not shown). 
Next, NA cells were labeled with [32p]orthophosphate for 
16 h, and treated with EGF or H20> followed by the im- 
munoprecipitation a alysis. H202 enhanced [3Zp]phosphate-in- 
corporation into EGF receptor within 2.5 rain and in a dose- 
dependent manner (Fig. 2). Interestingly, the level of H202- 
enhanced phosphorylation was only a half of the EGF-en- 
hanced phosphorylation (Fig. 2). 
3.2. Effective inhibition by antioxidant MnCI 2 of H202-enhanced 
EGF receptor tyrosine phosphorylation 
We examined the effects of an antioxidant MnCI2 on the 
EGF receptor tyrosine phosphorylation. H202 enhanced the 
EGF receptor phosphorylation when cells were labeled with 
[32p]orthophosphate nd treated with H202 in the absence of 
MnCI2 (Fig. 3). However, when cells were treated with H202 in 
the presence of MnC12, the substantial decrease in tyrosine 
phosphorylation was observed (Fig. 3). MnC12 had no effect on 
the EGF-enhancement of receptor tyrosine phosphorylation. 
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Fig. 1. H202-enhancement of tyrosine phosphorylation. NA cells were 
treated with EGF (50 ng/ml) or H202 (1 mM) for 15 min and then lysed. 
The extracts were subjected to immunoprecipitation by the anti-human 
EGF receptor antibody B4G7 and by anti-phosphotyrosine a tibody. 
After electrophoresis of the immunoprecipitate on SDS-polyacrylamide 
gel (7%) and transfer to a PVDF membrane, immunostaining analysis 
by anti-phosphotyrosine a tibody (A) and sheep anti-human EGF re- 
ceptor antibody (B) was carried out. 
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Fig. 2. H202-enhancement of EGF receptor phosphorylation. NA cells 
were labeled with [32p]orthophosphate and treated with EGF or H202 
at various doses (A) and at various times (B) in DMEM/FBS10. After 
immunoprecipitation of the EGF receptor with B4G7 antibody and 
transfer to a PVDF membrane, autoradiography and quantitative anal- 
ysis was carried out using a BAS2000 Bio-imaging analyzer. Open 
circles, EGF; closed circles, H202. 
3.3. Tryptic phospho-peptide mapping of H202-enhanced 
phosphorylation of EGF receptor 
To identify the H202-enhanced phosphorylation sites in the 
EGF receptor, tryptic phosphopeptide mapping and phospho- 
amino acid analysis was carried out (Fig. 4). Each phos- 
phorylated residue on the EGF receptor was identified from the 
comparison with previous works [5-7,12]. 
In control cells, the EGF receptor was phosphorylated on 
threonine 669 (fraction 67, Peptide 3 in Fig. 4) and moderately 
on serine 1,046 and 1,047 (fractions 80-82, Peptide 4). EGF- 
enhanced phosphorylation f the EGF receptor was remarka- 
ble on five specific residues including serine 671 (fraction 65, 
Peptide 3), serine 1,046 and 1,047 (fractions 78-82, Peptide 4), 
threonine 669 (fraction 67, Peptide 3) and tyrosine 1,173 (frac- 
tion 43, Peptide 2). In contrast, H202-enhanced phosphoryla- 
tion was remarkable on serine 1,046 and 1,047 (fractions 77-82, 
Peptide 4), threonine 654 (fraction 31, Peptide 1) and 669 (frac- 
tion 67, Peptide 3) and tyrosine 1,173 (fraction 44, Peptide 2). 
In addition to tyrosine 1,173, three tyrosine-phosphorylations 
were detected in fractions 77-80, fraction 67, and fractions 
54~57. Thus, HzO2-enhanced phosphorylation f the EGF re- 
ceptor was extensive on tyrosine residues much more than 
EGF-enhanced phosphorylation. 
3.4. Enhancement of in vitro phosphorylation of EGF receptor 
by H202 
Finally, in vitro phosphorylation assay was carried out using 
the membrane fractions prepared from NA cells. Dose-depend- 
ent enhancement of EGF receptor tyrosine phosphorylation 
was observed when H202 was added (Fig. 5A), while the same 
amount of EGF receptor was present (Fig. 5B). Thus, H202- 
stimulation of EGF receptor tyrosine phosphorylation was re- 
produced in vitro. 
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Fig. 3. Effects of antioxidant MnCI 2 on H2Oz-enhanced tyrosine phos- 
phorylation. NA cells were labeled with [32P]orthophosphate for 16 h 
in DMEM/FBS10. The cells were pretreated with fresh MnC12 (1 mM) 
for 15 rain, and then treated with EGF or H2Oz for 15 min. After 
immunoprecipitation a d transfer to a membrane, autoradiography 
(A) and immunostaining using anti-phosphotyrosine a tibody (B) was 
carried out as described in Fig. 1. 
4. Discussion 
In this study, we described the remarkable nhancement of
EGF receptor tyrosine phosphorylation by H202 in an EGF 
receptor hyperproducing NA cells, This is not a peculiar phe- 
nomenon to NA cells because it was observed also in other cell 
lines including A431 (an EGF receptor hyperproducer derived 
from epidermoid carcinoma), HeLa (derived from epidermoid 
carcinoma) and A549 (derived from adenocarcinoma). The 
HzO2-treatment (1 mM for 15 min) induced membrane raffling, 
but resulted in neither eceptor internalization nor cell growth 
inhibition (unpublished results). 
The initial event after EGF binding is the autophosphoryla- 
tion of EGF receptor on tyrosine residues. Previous studies 
under in vitro phosphorylation conditions demonstrated the 
presence of at least five tyrosine phosphorylated peptides in the 
EGF-activated receptor (Fig. 4B) [5 7]. In contrast, the studies 
under in vivo conditions demonstrated a single tyrosine phos- 
phorylation site at 1,173 of the EGF receptor isolated from 
EGF-treated cells [1,12]. Besides tyrosine phosphorylation, 
serine/threonine phosphorylation is abundant and involved in 
the attenuation of the EGF-activated EGF receptor [8 11]. 
Thus, the half level of phosphorylation in H zOz-activated recep- 
tor, especially the low level of serine/threonine phosphoryla- 
tion, may result in an insufficient attenuation of receptor func- 
tion, such as lack of receptor internalization. 
The H202-stimulation f EGF receptor tyrosine phosphoryl- 
ation was reproduced using NA cells membrane fractions. This 
suggests a possibility that H2Oz directly activates the intrinsic 
Fig. 4. Phospho-peptide mapping of H2Oz-enhanced EGF receptor 
phosphorylation. (A) NA cells were labeled with [32p]orthophosphate 
and treated with EGF or H202 in DMEM/FBSI0. After immunopre- 
cipitation and transfer to a membrane, the EGF receptor was digested 
with trypsin. The resulting peptide was fractionated with an acetonitrile 
gradient of 0% to 50% (fraction 10 through 110) in the presence of 
trifluoroacetic acid on C18 column (Left). Indicated fractions were 
subjected to phospho-amino acid analysis (Right). S, T and Y indicate 
phosphoserine, phosphothreonine and phosphotyrosine, r spectively. 
(B) Summary of phosphorylation sites in the EGF receptor. Peptides 
1 through 4 were identified by peptide mapping, whereas peptides 5
through 7 have not been mapped. 
tyrosine kinase of the EGF receptor and phosphorylate hree 
additional tyrosine residues that are scarcely phosphorylated 
under physiological conditions for EGF stimulation (see Fig. 
4B as summary). Alternatively, it is also possible that H20 2 
activates an unidentified membrane tyrosine kinase(s) which is 
closely associated with EGF receptor. 
It is known that MnClz mimics a function of the intracellular 
scavenger superoxide dismutase [19]. In our study, freshly pre- 
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Fig. 5. In vitro phosphorylation f EGF receptor by H202. The mem- 
brane fraction was prepared from NA cells. In vitro phosphorylation 
assay was carried out in the presence of EGF (100 ng) and various 
concentrations of H202. After electrophoresis on SDS-polyacrylamide 
gel and transfer to PVDF membrane, immunostaining using anti- 
phosphotyrosine antibody (A) and sheep anti-human EGF receptor 
antibody (B) was carried out as described in Fig. 1. 
pared MnC12 inhibited H202-enhancement of the EGF receptor 
tyrosine phosphorylation i vivo. This observation suggests 
that H202 effect on EGF receptor is through generation of 
oxidant stress. Interestingly, it was recently demonstrated that 
oxygen radicals generated by ultraviolet irradiation, H20 z 
treatment or from xanthine by xanthine oxidase can activate src 
kinase, mitogen-activated protein kinase raf-1 kinase and ribo- 
somal $6 protein kinase [20-22]. Those studies provided no 
evidence for the involvement of EGF receptor. 
Oxidants are generated in tissues under various circum- 
stances, including inflammation, hypoxia followed by reperfu- 
sion, and hyperoxia. The present study provided an additional 
viewpoint hat the EGF receptor may be regulated by oxidant 
stress through the unique tyrosine phosphorylation mecha- 
nism. 
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